- Home
- DAO vs XERS Comparison
DAO vs XERS Comparison
Compare DAO & XERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DAO
- XERS
- Stock Information
- Founded
- DAO 2006
- XERS 2005
- Country
- DAO China
- XERS United States
- Employees
- DAO N/A
- XERS N/A
- Industry
- DAO Other Consumer Services
- XERS Biotechnology: Pharmaceutical Preparations
- Sector
- DAO Real Estate
- XERS Health Care
- Exchange
- DAO Nasdaq
- XERS Nasdaq
- Market Cap
- DAO 1.1B
- XERS 1.3B
- IPO Year
- DAO 2019
- XERS 2018
- Fundamental
- Price
- DAO $10.96
- XERS $8.24
- Analyst Decision
- DAO
- XERS Strong Buy
- Analyst Count
- DAO 0
- XERS 7
- Target Price
- DAO N/A
- XERS $8.00
- AVG Volume (30 Days)
- DAO 84.0K
- XERS 2.1M
- Earning Date
- DAO 11-13-2025
- XERS 11-07-2025
- Dividend Yield
- DAO N/A
- XERS N/A
- EPS Growth
- DAO N/A
- XERS N/A
- EPS
- DAO 0.27
- XERS N/A
- Revenue
- DAO $785,636,394.00
- XERS $246,025,000.00
- Revenue This Year
- DAO $5.78
- XERS $43.89
- Revenue Next Year
- DAO $13.12
- XERS $20.40
- P/E Ratio
- DAO $37.94
- XERS N/A
- Revenue Growth
- DAO N/A
- XERS 35.62
- 52 Week Low
- DAO $4.21
- XERS $2.73
- 52 Week High
- DAO $11.82
- XERS $8.51
- Technical
- Relative Strength Index (RSI)
- DAO N/A
- XERS 56.10
- Support Level
- DAO N/A
- XERS $7.95
- Resistance Level
- DAO N/A
- XERS $8.39
- Average True Range (ATR)
- DAO 0.00
- XERS 0.33
- MACD
- DAO 0.00
- XERS -0.02
- Stochastic Oscillator
- DAO 0.00
- XERS 57.29
About DAO Youdao Inc. each representing one
Youdao Inc develops and markets software applications. It engages in developing technologies to provide learning content, applications, and solutions. The firm operates in three segments: Learning services, Smart devices, and Online marketing services. The majority of its revenue comes from the Learning services segment, which generates revenues from online courses, mainly including Youdao Premium Courses, NetEase Cloud Classroom, and China University MOOC. The learning products segment includes sales of smart devices such as the Youdao Dictionary Pen and the Youdao Pocket Translator. Geographically, all of its revenue is generated from the People's Republic of China.
About XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).